Patricia Drake
Corporate Officer/Principal at TREVENA, INC.
Net worth: 43 795 $ as of 29/04/2024
Network origin in Patricia Drake first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 15 | |
Extinct | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Patricia Drake via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | General Counsel | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Sales & Marketing | |
MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
NEURONETICS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer Chief Tech/Sci/R&D Officer | |
St. Michael's Hospital
St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member | |
ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree | |
University of Toronto | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal | |
University of Western Ontario | College/University | Undergraduate Degree | |
Southern Illinois University | College/University | Masters Business Admin Undergraduate Degree | |
Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
Royal College of Physicians & Surgeons of Canada
Royal College of Physicians & Surgeons of Canada Other Consumer ServicesConsumer Services The Royal College of Physicians & Surgeons of Canada operates a college for medical professionals. The non-profit company is based in Ottawa, Canada. The CEO of the Canadian company is Andrew Padmos. | Other Consumer Services | Corporate Officer/Principal | |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Wellesley Hospital | Corporate Officer/Principal | ||
Center for Drug Evaluation & Research | General Government | Corporate Officer/Principal | |
The American Society for Clinical Pharmacology & Therapeutics
The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Miscellaneous Commercial Services | President | |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | General Counsel | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | President | |
Columbia College (New York) | College/University | Undergraduate Degree | |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chairman | |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Alopexx Enterprises LLC
Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Biotechnology | Director/Board Member | |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Director/Board Member | |
Perseus Holdings USA LLC
Perseus Holdings USA LLC Electronics DistributorsDistribution Services Perseus Holdings USA LLC markets vaccine platform technology. The company is headquartered in Austin, TX. | Electronics Distributors | Director/Board Member | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Accelerating Therapeutics for Opportunities in Medicine
Accelerating Therapeutics for Opportunities in Medicine Packaged SoftwareTechnology Services Accelerating Therapeutics for Opportunities in Medicine (ATOM) is an American company that focuses on molecular design and modeling programs. The private company works with open-source software and AMPL packages to build models and analyze data. The company collaborates with Lawrence Livermore National Laboratory scientists to fight against COVID-19 by combining artificial intelligence/machine learning, bioinformatics, and supercomputing to help discover drugs. ATOM shares updates about their new partners, technical team members, and presentations on their website. | Packaged Software | Director/Board Member | |
Exacis Biotherapeutics, Inc.
Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Medical/Nursing Services | Chairman | |
BARINTHUS BIOTHERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
ALOPEXX, INC. | Biotechnology | Director/Board Member | |
Medical Dictionary For Regulatory Activities | Corporate Officer/Principal | ||
Aerium Therapeutics, Inc.
Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
United States | 39 |
Canada | 7 |
United Kingdom | 4 |
Singapore | 2 |
Austria | 2 |
Sectoral
Health Technology | 26 |
Consumer Services | 9 |
Commercial Services | 8 |
Health Services | 4 |
Government | 3 |
Operational
Director/Board Member | 117 |
Corporate Officer/Principal | 55 |
Independent Dir/Board Member | 54 |
Undergraduate Degree | 22 |
Chief Executive Officer | 15 |
Most connected contacts
Insiders | |
---|---|
Lonnie Moulder | 31 |
Mark Corrigan | 29 |
Scott Braunstein | 26 |
Jake Nunn | 23 |
Peter Honig | 20 |
Michael Dougherty | 18 |
Anne Phillips | 14 |
Barbara Yanni | 13 |
John Knighton | 9 |
Mark Demitrack | 8 |
Todd L. Wandstrat | 7 |
Carrie Bourdow | 6 |
Julie Hoff | 5 |
Marvin Johnson | 5 |
Barry Shin | 5 |
- Stock Market
- Insiders
- Patricia Drake
- Company connections